MEDS earnings · rev $23.3M
MEDS (MEDS) common stock.
This MEDS earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported MEDS revenue for 2025-12-31 was $23.3M. Net income was -$101.3M. Revenue was up 28.7% from 2024-12-31 to 2025-12-31.
When the next MEDS 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 28.7% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full MEDS research stays on the stock page; the tape stays on the quote page.
Not investment advice.